A new study finds four factors that may make it more likely for some people to experience successful weight loss from using GLP-1Rs such as Ozempic or Wegovy.

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using GLP-1Rs such as Ozempic or Wegovy.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those ...

UK health authorities are investigating pancreatitis cases linked to weight-loss drugs like Ozempic and Mounjaro. We spoke to doctors for clarity on risks, side effects, and the role of genetics.

GLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology — Diet and exercise no longer the main first-line strategies for weight management ...

Could China’s New GLP-1 Drugs Beat Out Ozempic? GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 ...

Ozempic-like drug significantly reduces frequency of chronic migraines in pilot study by Krystal Kasal, Phys.org edited by Gaby Clark, reviewed by Robert Egan Editors' notes ...

In his response, the Ethicist noted: “GLP-1 drugs, such as Ozempic, have helped many people break that cycle. Still, even sound advice can land wrong if it touches a nerve.

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

Arabian Post -A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a chronic disease. The product, from Novo Nordisk, is licensed ...

Sharon Osbourne is making headlines with her new look, following her use of the diabetes drug Ozempic – but probably not in the way she’d hoped for. Ozempic has become one of the most popular ...

Among the drugs picked for negotiation is the blockbuster weight-loss medication sold as Ozempic and Wegovy. The new exemptions will apply to the third round, affecting prices starting in 2028.